🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib/II trial studies the side effects and best dose of toll-like ...
Status
Completed
Location
Stanford University, School of Medicine
Start Date
2016-11-07
Trial ID
NCT02927964
Treatments Being Tested
The goal of this Phase 1b clinical trial is to evaluate the safety and effi...
Status
Active Not Recruiting
Location
University of California, San Diego
Start Date
2025-01-03
Trial ID
NCT06710223
Treatments Being Tested
The main purpose of this study is to assess the safety, tolerability, and b...
Status
Completed
Location
Healthcare Discoveries, Inc.
Start Date
2008-01
Trial ID
NCT00599001
This phase 1-2 trial studies the side effects and best dose of ipilimumab i...
Status
Completed
Location
Stanford University Hospitals and Clinics
Start Date
2014-09
Trial ID
NCT02254772
Treatments Being Tested
The purpose of this study is to further advance the ability to practice per...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2010-03-01
Trial ID
NCT01042379
Treatments Being Tested
To determine safety, tolerability, and preliminary efficacy of escalating d...
Status
Completed
Location
Klinika Chorób Zakaźnych i Hepatologii Collegium Medicum Uniwersytet Mikołaja Kopernika
Start Date
2008-10
Trial ID
NCT00823862
To assess the safety and tolerability of escalating doses of SD-101 in comb...
Status
Terminated
Location
Stanford University School of Medicine
Start Date
2014-10
Trial ID
NCT02266147
Treatments Being Tested
This study is an open-label, phase 1/1b study of the pressure-enabled intra...
Status
Active Not Recruiting
Location
MD Anderson Cancer Center
Start Date
2023-03-01
Trial ID
NCT05607953
This is a non-comparative open-label multicenter Phase 2 clinical trial com...
Status
Completed
Location
University of California San Francisco
Start Date
2017-05-17
Trial ID
NCT03007732
Checkpoint blockade immunotherapy has revolutionized the management of a va...
Status
Completed
Location
University of California Davis Comprehensive Cancer Center
Start Date
2018-01-17
Trial ID
NCT03322384
Treatments Being Tested